A leader in the success game: Enfusion Inc. (ENFN) Stock

William Blair raised the price target for the Enfusion Inc. (NYSE:ENFN) stock to ‘an Outperform’. The rating was released on November 15, 2021, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $26. The stock was initiated by Morgan Stanley, who disclosed in a research note on November 15, 2021, to Equal-Weight and set the price objective to $24. In their research brief published November 15, 2021, Goldman analysts initiated the Enfusion Inc.